Project Details
Description
A Randomized, Open-Label, Phase 3 Trial of NOV-002 in Combination with Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-small Cell Lung Cancer...
Status | Finished |
---|---|
Effective start/end date | 1/19/07 → 10/31/10 |
Funding
- ICON CLINICAL RESEARCH, INC
- NOVELOS THERAPEUTICS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.